Course Provider
Learning Objectives
Participants will discuss the current treatment options and the rationale for the development of novel treatment options for Richter transformation.
Participants will review evidence from clinical trials supporting the use of targeted therapy for the treatment of Richter transformation.
Participants will develop an individualized treatment plan for Richter transformation based on prior treatment of CLL/SLL and clonal relationship.